@article{da12591adc184409a13ce51b6ac05afa,
title = "Conference Report: Psychiatric Genomics Consortium Meeting: Pathways to Drugs, London, March 2017",
author = "Gaspar, \{H{\'e}l{\'e}na A.\} and Collier, \{David A.\} and Geschwind, \{Daniel H.\} and Lewis, \{Cathryn M.\} and Qingqin Li and Roth, \{Bryan L.\} and Sullivan, \{Patrick F.\} and Gerome Breen",
note = "Funding Information: DAC reports employment by Eli Lilly and Company, QL reports employment by Janssen Research and Development, and GB acknowledges funding from Eli Lilly and Illumina, Inc. HAG, DHG, CML, PFS, and BLR report no biomedical financial interests or potential conflicts of interest. Funding Information: This work was supported by the United Kingdom National Institute for Health Research Biomedical Research Centre at South London and Maudsley National Health Service Foundation Trust and King{\textquoteright}s College London (to GB, HAG, CML). The views expressed are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health. ",
year = "2018",
month = sep,
day = "15",
doi = "10.1016/j.biopsych.2018.01.024",
language = "English",
volume = "84",
pages = "e49--e50",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier Inc.",
number = "6",
}